These lab-manufactured alternatives were not made with leisure use in mind. While in the 1990s, John W. Huffman as well as a staff of fellow chemists at Clemson College developed some of the very first formulas for synthetic cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impacts of can